Ellenberg S S, Chen R T
Division of Biostatistics and Epidemiology, FDA, USA.
Public Health Rep. 1997 Jan-Feb;112(1):10-20; discussion 21.
Vaccination is an essential component of modern public health programs and is among our most cost-effective medical interventions. Yet despite vaccines' clear effectiveness in reducing risks of diseases that previously attacked large proportions of the population, caused many deaths, and left many people with permanent disabilities, current vaccination policies are not without controversy. Vaccines, like all other pharmaceutical products, are not entirely risk-free; while most known side effects are minor and self-limited, some vaccines have been associated with very rare but serious adverse effects. Because such rare effects are often not evident until vaccines come into widespread use, the Federal government maintains ongoing surveillance programs to monitor vaccine safety. The interpretation of data from such programs is complex and is associated with substantial uncertainty. A continual effort to monitor these data effectively and to develop more precise ways of assessing risks of vaccines is necessary to ensure public confidence in immunization programs.
疫苗接种是现代公共卫生项目的重要组成部分,也是我们最具成本效益的医疗干预措施之一。然而,尽管疫苗在降低以前侵袭很大一部分人口、导致许多人死亡并使许多人留下永久性残疾的疾病风险方面具有明显效果,但目前的疫苗接种政策并非没有争议。与所有其他药品一样,疫苗并非完全没有风险;虽然大多数已知的副作用较小且具有自限性,但一些疫苗与非常罕见但严重的不良反应有关。由于此类罕见影响往往在疫苗广泛使用后才显现出来,联邦政府持续开展监测项目以监测疫苗安全性。对此类项目数据的解读很复杂,且存在很大不确定性。必须持续努力有效监测这些数据,并开发更精确的方法来评估疫苗风险,以确保公众对免疫项目的信心。